Tred Avon Family Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Buy
10,584
+49
+0.5% +$10.5K 0.82% 24
2026
Q1
$2.29M Buy
10,535
+642
+6% +$142K 0.76% 26
2025
Q4
$2.26M Buy
9,893
+1,289
+15% +$294K 0.74% 28
2025
Q3
$1.99M Buy
+8,604
New +$1.75M 0.68% 30

Other funds holding ABBV

Tred Avon Family Wealth's ABBV Position: Q2 2026 in Review

Tred Avon Family Wealth increased its AbbVie (ABBV) stake by 0.47% in Q2 2026, buying an estimated $10.5K and bringing the position to 10,584 shares worth $2.66M. The position accounts for 0.82% of the portfolio, ranked #24.

Tred Avon Family Wealth first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tred Avon Family Wealth held 10,584 shares of AbbVie worth $2.66M as of Q2 2026.
  • Tred Avon Family Wealth bought 49 AbbVie shares in Q2 2026, an estimated $10.5K.
  • AbbVie made up 0.82% of Tred Avon Family Wealth's portfolio in Q2 2026, its #24 holding.
  • Tred Avon Family Wealth first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tred Avon Family Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.